External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

EULAR 2024

June 12 - June 15

Vienna, Austria

eular.org

Add to calendar

Medical Materials

Agenda

Coming soon

01:30 PM

Duration 1hr Vienna, Austria

Obinutuzumab benefits patients with active lupus nephritis irrespective of baseline proteinuria severity: a post hoc analysis of the Phase II NOBILITY trial

Furie R, Terres J, Martins E, Hassan I, Schindler T, Garg J, Pendergraft W, Malvar A, Rovin B

Nephrology | Lupus nephritis

Add to calendar

02:30 PM

Duration 10mins Session Room C8

Longitudinal Assessment of Biomarkers in NOBILITY, a Randomized, Phase II Clinical Trial of Obinutuzumab for Treatment of Proliferative Lupus Nephritis

Edward M. Vital

Nephrology | Lupus nephritis

Add to calendar

10:00 AM

Duration 90mins Vienna, Austria

Evaluating the concordance between SRI-4 and BICLA in the EXPLORER and ATHOS trials in active systemic lupus erythematosus

Askanase A, Vital E, Terres J, Maller J, Meier O, Turchetta A, Mao A, Dall'Era M

Immunology | Systemic Lupus Erythematosus

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.